IkT-148x

N/A

Report date: 2024/12/20 10:15:24
NME

Base Information

Drug NameIkT-148x
Drug Alias NameIkT-148x
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-tyrosine kinases inhibitors
TargetsProtein-tyrosine kinases
Therapy Area/IndicationsLewy Body DiseaseMultiple System Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesInhibikase Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesInhibikase Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLewy Body DiseaseMultiple System Atrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A